We are proud to be recognized for our technology. As a Vizient partner, our goal is to deliver this technology while driving cost savings through lower acquisition costs and reduce downstream expenses.
GENEVA, Ill. (PRWEB) February 21, 2019
Cura Surgical announced its Silverlon Antimicrobial Surgical Dressings have received a 2018 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The designation was based on the recommendations of health care experts serving on a member-led council who interacted with the product shown at the Vizient Innovative Technology Exchange held on Oct. 4, 2018. The council determined the technology had the potential to enhance clinical care, patient safety, health care worker safety or improves business operations of health care organizations.
Containing more metallic silver than any other silver-based dressing, Silverlon Antimicrobial Surgical Dressings are supported by multiple, peer-reviewed clinical studies demonstrating the effectiveness of Silverlon technology across multiple specialties. When activated by moisture, silver ions are released in the dressing, providing immediate antimicrobial activity and a protective barrier against a broad spectrum of pathogens including MRSA and pseudomonas.
“We are proud to be recognized for our technology” states Raul Brizuela, CEO of Cura Surgical. “As a Vizient partner, our goal is to deliver this technology while driving cost savings through lower acquisition costs and reduce downstream expenses.”
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to review potentially innovative products. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
Silverlon wound dressings have a permanently plated metallic surface, which provides the antimicrobial benefits of silver in the dressing without staining the skin and without increasing bioburden. Silverlon was originally developed for the U.S military, where it is still extensively used for management of burn and blast injuries. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, in negative pressure wound therapy, and chronic wounds, burns, skin grafts, and IV and catheter-related wounds. For more, visit http://www.silverlon.com.
About Cura Surgical®
Cura Surgical specializes in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon® technology in keeping with its corporate mission to improve clinical outcomes.